Current position:Home >Product >
2-Chryseneaceticacid, octadecahydro-2,4a,6a,7,10b,12a-hexamethyl-, (2R,4aR,4bS,6aR,7S,10aR,10bS,12aS)-
2-Chryseneaceticacid, octadecahydro-2,4a,6a,7,10b,12a-hexamethyl-, (2R,4aR,4bS,6aR,7S,10aR,10bS,12aS)-(15399-34-5)
- Name: 2-Chryseneaceticacid, octadecahydro-2,4a,6a,7,10b,12a-hexamethyl-, (2R,4aR,4bS,6aR,7S,10aR,10bS,12aS)-
- Synonyms:D-Homo-5a-androstane-3a-acetic acid,3,5,8,17ab-tetramethyl- (8CI); D-Homoandrostane-3-acetic acid,3,5,8,17a-tetramethyl-,(3a,5a,17ab)-; 2-Chryseneacetic acid, octadecahydro-2,4a,6a,7,10b,12a-hexamethyl-, [2R-(2a,4ab,4ba,6ab,7b,10aa,10bb,12aa)]-; Tetranorshionan-23-oic acid; Tetranorshionanoicacid
- Molecular Formula:C26H44 O2
- Molecular Weight:
- CAS Registry Number:15399-34-5
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 54860-84-3/ethyl N-phenylalaninate
- 58418-20-5/3-[hydroxy(methyl)amino]-2H-indol-2-one
- 5449-02-5/dihydroxy-oxo-azanium; 4-dimethylamino-2,2-diphenyl-pentanal
- 92765-68-9/2-morpholin-4-yl-8-thioxo-3,7,8,9-tetrahydro-6H-purin-6-one
- 59166-15-3/4-(4-chlorophenyl)-1,3,8-trimethyl-4,8-dihydro-1H-pyrazolo[3,4-e][1,4]thiazepin-7(6H)-one
- 90749-42-1/1H-Purine-2,6-dione,8-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethyl]-3,9-dihydro-1-methyl-3-(2-methylpropyl)-
- 21399-33-7/4-METHYLACETOPHENONE AZINE
- 180850-95-7/Benzenesulfonic acid, 2,2-(1E)-1,2-ethenediylbis5-4-(methylamino)-6-4-(methylamino)carbonylphenylamino-1,3,5-triazin-2-ylamino-, disodium salt
- 925-69-9/6-methyloctan-2-one
- 7466-24-2/(4Z)-5-hydroxy-4-[1-(hydroxyamino)ethylidene]-2-nitrocyclohexa-2,5-dien-1-one
- 77029-65-3/Poly(oxy-1,8-octanediyl),a-(4-ethylphenyl)-w-hydroxy-
- 61792-30-1/17-(4,5-dihydro-1H-imidazol-2-yl)heptadec-9-en-7-ol
- 81203-56-7/penstemonoside
- 28563-18-0/6-chloro-4-hydroxy-3-phenyl-2(1H)-quinolinone
- 132418-42-9/4H-Pyrido[4',3':4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-9(8H)-carbothioamide,6-(2-chlorophenyl)-7,10-dihydro-1-methyl-N-[3-(trifluoromethyl)phenyl]-
- 15399-34-5/2-Chryseneaceticacid, octadecahydro-2,4a,6a,7,10b,12a-hexamethyl-, (2R,4aR,4bS,6aR,7S,10aR,10bS,12aS)-
- 5140-72-7/2-BROMO-6-CHLOROPYRIDINE
- 119121-86-7/4-(4-chlorophenyl)-N-[(E)-phenylmethylidene]-1,3-oxazol-2-amine
- 26306-64-9/2-(2,4-Dichlorophenoxy)aniline
- 94108-44-8/1-docosyl-5-oxopyrrolidine-3-carboxylic acid
- 84118-71-8/1,3-bis(2-methylphenyl)but-2-en-1-one
- 6120-00-9/naphthalen-1-yl methyl(trimethylsilyl)carbamate
- 7151-45-3/Quinoxaline, 1,4-diacetyl-1,2,3,4-tetrahydro- (9CI)
- 80901-81-1/methyl 7-(acetyloxy)-5,23,25,26-tetrahydroxy-4,8,12,16,19,19,24,26,28,29-decamethyl-11,30-dioxo-10,11,16,17,21,22,23,24,25,26-decahydro-6,9:17,21-dimethano[1,3]dioxino[4,5,6-wx][12,14,4]benzodioxazacyclopentacosine-22-carboxylate
- 53793-31-0/1,4-Octadiene,(4E)-
- 73168-30-6/Benzoicacid, 4-(3,3-dimethyl-1-triazen-1-yl)-, 2-[(3-nitrophenyl)methylene]hydrazide
- 1928-89-8/6-(pyrrolidin-1-yl)-5H-purine
- 6320-08-7/3-(hydroxyamino)-3-phenylpropanoic acid
- 101670-44-4/Hyalodendrin II (9CI)
- 54100-47-9/(4-tert-butylphenyl)(oxo)sulfanylphosphonium